Predictors of Success of Different Treatment Modalities for Management of Ectopic Pregnancy

Table 3

Demographic and clinical characteristics of all patients treated with Mtx in EP.

	Group 1 () (success group) (SEM^1-%)	Group 2 () (failure group) (SEM^1-%)
Age (years)	30.77 ± 0.70	30.27 ± 1.06	0.696
Gravidity	2.54 ± 0.16	3.10 ± 0.34	0.150
Parity	0.89 ± 0.10	1.24 ± 0.22	0.174
βhCG^2 (day 0)
<1000 (mIU/mL)	31 (86.11%)	5 (13.89%)	<0.01
1000–3000 (mIU/mL)	22 (84.61%)	4 (15.39%)
3000–10000 (mIU/mL)	11 (42.30%)	15 (57.7%)
>10000 (mIU/mL)	4 (36%)	5 (64%)
βhCG^2 (1st day) (mIU/mL)	2535.22 ± 486.19	6463.06 ± 1245.42	0.06
βhCG^2 (4th day) (mIU/mL)	2187.70 ± 436.81	7434 ± 1668.68	0.05
βhCG^2 (7th day) (mIU/mL)	1584.66 ± 298.92	2446.79 ± 1688.29	0.01
Diameter of EP^3 mass (mm)
<25 mm	50 (89.28%)	6 (10.72%)	<0.01
25–35 mm	10 (52.63%)	9 (47.37%)
>35 mm	8 (36.36%)	14 (63.64%)
Endometrial thickness (mm)	6.41 ± 0.48	7.45 ± 0.70	0.229

SEM: standard error of mean, ²βhCG: beta human chorionic gonadotropin, ³EP: ectopic pregnancy.
Statistical significance .